Status:
UNKNOWN
Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of this study is to assess the efficacy and safety of Luo-Fu-Shan Plaster in patients with Rheumatoid Arthritis.
Detailed Description
The investigators are inspired by Chinese traditonal herb, an therapy for thousands of years, and take its advantage to make Luo-Fu-Shan Plaster in order to get an effective and safe treatment for act...
Eligibility Criteria
Inclusion
- Male or female subjects aged 18 to 75 years (time of get informed consent)
- Documented diagnosis of rheumatoid arthritis, as defined by the American Rheumatism Association 1987 Revised Criteria.
- Documented diagnosis of damp-heat syndrome according to Traditional Chinese Medicine.
- If patients are receiving Disease-modifying anti-rheumatic drugs (DMARDs), then the doses should have been kept stable for at least 12 weeks.
- If patients are receiving non-steroidal anti-inflammatory drugs (NSAIDs) or orally Chinese herbal medicine, then the doses should have been kept stable for at least 4 weeks.
Exclusion
- Skin allergies or broken skin;
- Taking glucocorticoids,more than 10 mg daily.
- Female patients who are pregnant, breast-feeding or planed to be pregnant;
Key Trial Info
Start Date :
May 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04884880
Start Date
May 14 2021
End Date
April 30 2022
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China